ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors
ESMO-ESTRO关于放疗联合EGFR、ALK或BRAF/MEK抑制剂安全性的共识声明
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106076
van Aken, E S M; O'Cathail, S M; Gandhi, A K; Bussink, J; Castelo-Branco, L; Eriksen, J G; Argilés, G; Hiley, C T; Atkinson, V; Kaźmierska, J; Calles, A; Konopa, K; Le Rhun, E; McDonald, F; Mountzios, G; Putora, P M; Muoio, B; Ricardi, U; Westphalen, C B; Wrona, A; Boot, P; Pentheroudakis, G; Belka, C; Lordick, F; Marijnen, C A M; Martins-Branco, D; De Ruysscher, D; Barriuso, J; Devnani, B; de Jong, M C; Prelaj, A
